MicroRNAs, development of Barrett’s esophagus, and progression to esophageal adenocarcinoma

被引:21
|
作者
Cameron M Smith [1 ]
David I Watson [1 ]
Michael Z Michael [2 ]
Damian J Hussey [1 ]
机构
[1] Department of Surgery, Flinders University, Room 3D211, Flinders Medical Centre, Bedford Park, South Australia 5042, Australia
[2] Department of Gastroenterology & Hepatology, Flinders University, Bedford Park, South Australia 5042, Australia
关键词
Barrett’s esophagus; MicroRNA; Esophageal adenocarcinoma; Transdifferentiation; Tumour suppressor;
D O I
暂无
中图分类号
R735.1 [食管肿瘤]; R571 [食管疾病];
学科分类号
1002 ; 100201 ; 100214 ;
摘要
Barrett’s esophagus is a premalignant condition caused by gastroesophageal reflux. Once developed, it can progress through varying grades of dysplasia to esoph-ageal adenocarcinoma. Whilst it is well accepted that Barrett’s esophagus is caused by gastroesophageal reflux, the molecular mechanisms of its pathogenesis and progression to cancer remain unclear. MicroRNAs (miRNAs) are short segments of RNA that have been shown to control the expression of many human genes. They have been implicated in most cellular processes, and the role of miRNAs in disease development is be-coming increasingly evident. Understanding altered miRNA expression is likely to help unravel the molecular mechanisms that underpin the development of Barrett’s esophagus and its progression to cancer.
引用
收藏
页码:531 / 537
页数:7
相关论文
共 50 条
  • [31] Role of Submucosal Glands in the Development and Progression of Adenocarcinoma in Barrett's Esophagus
    Johncilla, Melanie
    Odze, Robert
    Agoston, Agoston
    MODERN PATHOLOGY, 2016, 29 : 177A - 177A
  • [32] Role of Submucosal Glands in the Development and Progression of Adenocarcinoma in Barrett's Esophagus
    Johncilla, Melanie
    Odze, Robert
    Agoston, Agoston
    LABORATORY INVESTIGATION, 2016, 96 : 177A - 177A
  • [33] BARRETT ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA
    SIEWERT, R
    WEISER, HF
    LEPSIEN, G
    PEIPER, HJ
    CHIRURG, 1979, 50 (11): : 675 - 680
  • [34] Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma
    Jing Lv
    Lei Guo
    Ji-Jun Liu
    He-Ping Zhao
    Jun Zhang
    Ji-Han Wang
    World Journal of Gastroenterology, 2019, 25 (18) : 2149 - 2161
  • [35] Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma
    Lv, Jing
    Guo, Lei
    Liu, Ji-Jun
    Zhao, He-Ping
    Zhang, Jun
    Wang, Ji-Han
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (18) : 2149 - 2161
  • [36] Comprehensive Profiling of Plasma MicroRNAs Reveals Potential Biomarkers for Barrett's Esophagus and Esophageal Adenocarcinoma
    van Baal, Jantine W.
    Bus, Pauline
    Kestens, Christine
    Ten Kate, Fiebo T.
    Peters, Wilbert H.
    Drenth, Joost P.
    Roodhart, Jeanine
    Voest, Emiel E.
    Siersema, Peter D.
    GASTROENTEROLOGY, 2014, 146 (05) : S97 - S97
  • [37] Alterations in the immune microenvironment during progression from Barrett's esophagus to esophageal adenocarcinoma
    McEwen, Dyke P.
    Nancarrow, Derek J.
    Lin, Jules
    Reddy, Rishindra M.
    Chang, Andrew C.
    Beer, David G.
    Lagisetty, Kiran H.
    CANCER RESEARCH, 2019, 79 (13)
  • [38] Risk Factors for Progression of Barrett's Esophagus to High Grade Dysplasia and Esophageal Adenocarcinoma
    Kambhampati, Swetha
    Tieu, Alan H.
    Luber, Brandon
    Wang, Hao
    Meltzer, Stephen J.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [39] Aberrantly methylated PKP1 in the progression of Barrett's esophagus to esophageal adenocarcinoma
    Kaz, Andrew M.
    Luo, Yanxin
    Dzieciatkowski, Slavomir
    Chak, Amitabh
    Willis, Joseph E.
    Upton, Melissa P.
    Leidner, Rom S.
    Grady, William M.
    GENES CHROMOSOMES & CANCER, 2012, 51 (04): : 384 - 393
  • [40] Antireflux surgery to prevent the progression from Barrett's esophagus to esophageal adenocarcinoma: yes or no?
    Patti, Marco G.
    Herbella, Fernando A.
    Schlottmann, Francisco
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (04) : 1916 - 1918